BioNTech SE (BNTX) Net Income (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Net Income data on file, last reported at -$355.0 million in Q4 2025.

• For the quarter ending Q4 2025, Net Income fell 228.03% year-over-year to -$355.0 million; the trailing twelve-month figure through Dec 2025 stood at -$1.3 billion (down 76.14% YoY), and the FY2025 full-year result was -$1.3 billion, down 80.55% from the prior year.
• Net Income eased to -$355.0 million in Q4 2025, from -$33.6 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $7.2 billion in Q3 2021 to a low of -$869.9 million in Q2 2024.
• A 5-year average of $2.0 billion and a median of $385.0 million in 2023 frame the typical range for Net Income.
• Across the five-year window, Net Income soared 13561718996.32% in 2021 and sank 228.03% in 2025, its largest moves.
• Tracing BNTX's Net Income over 5 years: stood at $7.2 billion in 2021, then tumbled by 42.08% to $4.1 billion in 2022, then slumped by 88.13% to $492.7 million in 2023, then slumped by 43.72% to $277.3 million in 2024, then sank by 228.03% to -$355.0 million in 2025.
• Business Quant data shows BNTX's Net Income at -$355.0 million in Q4 2025, -$33.6 million in Q3 2025, and -$437.6 million in Q2 2025.